Douglas Lane & Associates’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,860
Closed -$337K 240
2025
Q1
$337K Hold
4,860
0.01% 205
2024
Q4
$418K Buy
4,860
+55
+1% +$4.73K 0.01% 191
2024
Q3
$572K Hold
4,805
0.01% 180
2024
Q2
$686K Buy
4,805
+63
+1% +$8.99K 0.01% 170
2024
Q1
$609K Hold
4,742
0.01% 176
2023
Q4
$491K Sell
4,742
-200
-4% -$20.7K 0.01% 178
2023
Q3
$449K Sell
4,942
-100
-2% -$9.09K 0.01% 176
2023
Q2
$408K Hold
5,042
0.01% 183
2023
Q1
$401K Sell
5,042
-92
-2% -$7.32K 0.01% 186
2022
Q4
$347K Sell
5,134
-1,358
-21% -$91.9K 0.01% 194
2022
Q3
$323K Sell
6,492
-300
-4% -$14.9K 0.01% 191
2022
Q2
$378K Hold
6,792
0.01% 189
2022
Q1
$377K Sell
6,792
-66
-1% -$3.66K 0.01% 192
2021
Q4
$384K Sell
6,858
-150
-2% -$8.4K 0.01% 193
2021
Q3
$336K Hold
7,008
﹤0.01% 193
2021
Q2
$294K Sell
7,008
-700
-9% -$29.4K ﹤0.01% 195
2021
Q1
$260K Sell
7,708
-100
-1% -$3.37K ﹤0.01% 194
2020
Q4
$273K Buy
7,808
+100
+1% +$3.5K ﹤0.01% 189
2020
Q3
$268K Sell
7,708
-370
-5% -$12.9K 0.01% 185
2020
Q2
$264K Buy
8,078
+1,060
+15% +$34.6K 0.01% 184
2020
Q1
$211K Sell
7,018
-6,202
-47% -$186K 0.01% 187
2019
Q4
$383K Buy
13,220
+420
+3% +$12.2K 0.01% 174
2019
Q3
$331K Hold
12,800
0.01% 182
2019
Q2
$327K Sell
12,800
-3,606
-22% -$92.1K 0.01% 188
2019
Q1
$429K Hold
16,406
0.01% 177
2018
Q4
$378K Buy
+16,406
New +$378K 0.01% 177
2017
Q4
Sell
-14,710
Closed -$354K 208
2017
Q3
$354K Sell
14,710
-35,210
-71% -$847K 0.01% 178
2017
Q2
$1.07M Sell
49,920
-30,430
-38% -$653K 0.03% 146
2017
Q1
$1.38M Sell
80,350
-56,456
-41% -$968K 0.03% 140
2016
Q4
$2.45M Sell
136,806
-187,886
-58% -$3.37M 0.06% 131
2016
Q3
$6.75M Sell
324,692
-158,624
-33% -$3.3M 0.18% 107
2016
Q2
$13M Sell
483,316
-114,802
-19% -$3.09M 0.37% 88
2016
Q1
$16.2M Buy
+598,118
New +$16.2M 0.44% 82